CHS Annual Report 2019

Over 2 Million People Reached By CHS In 2019

CHS provided a range of health services including HIV and TB prevention, treatment and care services to over 2 Million people between October 2018 and September 2019.

Corporate Highlights

CHS, Kenya’s Leading NGO in the Fight Against HIV and AIDS

CHS was named Kenya’s leading NGO in the fight against HIV/AIDS and among leading NGO sector players by the Kenya’s Nongovernmental Organisation (NGO) Coordination Board.

CHS Launches an Adolescent Adherence Mobile Application - Heroes App

With a commitment to improving treatment out- comes among adolescents living with HIV, CHS created and successfully launched a virtual plat- form dubbed the “Heroes App”.

Kenya Launches the National Strategic Plan (NSP) for Tuberculosis, Leprosy and Lung Health 2019-2023

CHS supported the National tubercu-losis leprosy and lung disease program (NTLD-P) in developing and launching Kenya’s National Strategic Plan (NSP) for Tuberculosis, Leprosy and Lung Health 2019-2023.

Focus Area: HIV/AIDS

Strengthening Health Systems for the Provision of HIV Testing and Prevention Services

CHS supports the country’s efforts to improve the health and wellbeing of its citizens by increasing the number aware of their HIV status, ensuring: those who test positive are linked to care and those that test negative have access to information that ultimately helps them make informed decisions about HIV prevention options.

Over 1.5 Million tested for HIV
9,763 initiated on PEP
4,777 initiated on PrEP

During this reporting period, 20,583 people were found to be HIV positive and 20,521 were started on treatment

Eliminating Mother to Child Transmission of HIV: Saving Future Generations

Nationally, progress towards the elimination of mother to child transmission of HIV has been noted with the Prevention of Mother to Child Transmission (PMTCT) coverage in- creasing from 23% in 2015 to 76% in 2017 and the EMTCT rate declining from 29.7% to 11.5% during the same period.

102,290 Pregnant women tested for HIV
5,901 women Identified with HIV
Over 2,000 Infants tested negative for HIV
Over 6,000 Infants started on ARV prophylaxis

Integrated HIV Prevention and Treatment Services for Key Populations

The World Health Organisation describes Key Populations (KP) as those that are more vulnerable and most-at-risk of HIV infection owing to either their lifestyle, profession or physiology. These include: men who have sex with men, sex workers, injecting drug users and transgender persons. Globally, key populations make up a small proportion of the general population, but they are at an extremely high risk of HIV infection.

Sexual and Gender Based Violence Care

During this reporting period CHS supported 27,802 victims of SGBV through; health care worker mentorship to ensure proper documentation and care for victims, awareness cre- ation and enhanced community based protection systems to improve GBV response and protection of victims; development of a one stop centre in Siaya County Referral Hospital whereby victims of sexual violence receive all services including, counselling, clinical assessment and legal assistance.

Staying the Course of HIV Treatment: Undetectable = Untransmittable

People living with HIV receiving effective antiretroviral treatment cannot transmit HIV sexually. Sustained antiretroviral therapy reduces the amount of HIV in the (viral load) to levels that are undetectable by a standard laboratory test, scientifically for as long as these levels are Undetectable then the virus is Untransmittable sexually.

Voluntary Medical Male Circumcision for HIV Prevention

Among the target population in Siaya County where CHS supports provision of VMMC ser- vices across all of Siaya’s six sub counties, the VMMC team successfully provided VMMC services to 47,754 men. Increased retention in care and encourage sustained adherence to ART thereby improving sustained viral suppression.

Focus Area: Tuberculosis

Promoting Access to High Quality Patient-Centred TB Services

In efforts to reduce the incidence and TB related morbidity and mortality in Kenya, CHS continued supporting the Ministry of Health’s National Tuberculosis, Leprosy and Lung Disease Program (NTLD-Program), through the United States Agency for International Development (USAID) funded Tuberculosis Accelerated Response and Care II activity (TB ARC II)

Using Technology to Find Tuberculosis

Nationally, progress towards the elimination of mother to child transmission of HIV has been noted with the Prevention of Mother to Child Transmission (PMTCT) coverage in- creasing from 23% in 2015 to 76% in 2017 and the EMTCT rate declining from 29.7% to 11.5% during the same period.

Over 80,000 TB Cases Notified
267, 752 Tests Conducted using Genexpert Machines

Increasing TB Awareness and Demand for TB Screening Services

CHS worked in partnership with its sub awardee, PS Kenya to increase TB awareness and demand for screening services through information sharing campaigns highlighting the six major symptoms of TB and a call to action ‘Pimwa TB, Tibiwa, Ishi Poa’ (Get screened for TB, get treated, and live well)

Laboratory Services

CHS has in place systems to ensure that laboratories within the network of supported facilities provide timely, quality assured, reliable and safe services. This is done through proficiency testing for services providers, trainings on biosafety and biosecurity, distribu- tion of test kits, as well as mentorship of county health workers.

CHS 2019 Annual Report

Read and download the entire report by clicking the button below.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.
You need to agree with the terms to proceed

Menu